Cartesian Therapeutics
RNAC
RNAC
106 hedge funds and large institutions have $186M invested in Cartesian Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.13% more ownership
Funds ownership: 1.5% → 1.63% (+0.13%)
14% less capital invested
Capital invested by funds: $217M → $186M (-$31.2M)
Holders
106
Holding in Top 10
1
Calls
$815K
Puts
$98K
Top Buyers
| 1 | +$6.49M | |
| 2 | +$4.57M | |
| 3 | +$4.04M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$3.59M |
| 5 |
Morgan Stanley
New York
|
+$2.62M |
Top Sellers
| 1 | -$8.87M | |
| 2 | -$4.26M | |
| 3 | -$2.69M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.75M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.55M |